Riskpilot← Back to searchSign inGet full accessMEDU MIDCO AS
ASActiveOrg 927496224Lilleakerveien 2B, 0283 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20210 employees
Revenue 2024
NOK 0
EBITDA margin
—
+29% vs 2023
Equity ratio
99.9%
Financial strength
Net profit 2024
NOK -65K
+29% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -65K | +29% |
| Net profit | NOK -65K | +29% |
| Total assets | NOK 142M | -30% |
| Equity | NOK 141,9M | -30% |
| Employees | 0 | — |
Legal name
MEDU MIDCO AS
Org number
927496224
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3. august 2021
Share capital
NOK 979 851
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Investering i aksjer.
Address
Lilleakerveien 2B, 0283 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | −6 | −35 | −92 | −65 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −6 | −35 | −92 | −65 |
| Net financials | 0 | 0 | 0 | 0 |
| Profit before tax | −6 | −35 | −92 | −65 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −6 | −35 | −92 | −65 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 75 804 | 99 559 | 201 800 | 142 039 |
| Equity | 75 804 | 99 544 | 201 687 | 141 861 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 15 | 113 | 178 |
| Total debt | 0 | 15 | 113 | 178 |
EBITDA margin
-6534700.0%
This company
15.8%
Market median
-41358961% vs market
20212024
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20212024
Return on equity
-0.0%
This company
18.4%
Market median
-100% vs market
20212024
Net profit margin
-6504400.0%
This company
8.1%
Market median
-80301335% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-07-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Board of Directors | 2021 – 2022 | |
| Chairman | 2021 – 2021 | |
| Chairman | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 99.51% | 99.51% | 2024 | |
| Company | 18.67% | 18.67% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Serendipity Partners Fund As
MEDU MIDCO AS Board members of MEDU MIDCO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christopher Segtnan Tangen | Chairman | 0 companies |
| Magne Stoknes | Board of Directors | 0 companies |
| Michael Bodd | Board of Directors | 0 companies |
| Kristian Brekke Djuve | Chairman | 0 companies |
| Synne Hermansen Røine | Chairman | 0 companies |